NASDAQ:KROS

Keros Therapeutics Insider Trades

$37.76

-0.74 (-1.92%)

(As of 05/19/2022 01:55 PM ET)

Add

Compare

Today's Range: $36.94
▼
$39.40
50-Day Range: $38.50
▼
$67.04
52-Week Range: $28.50
▼
$68.29

Volume: 2,277 shs
Average Volume: 139,560 shs
Market Capitalization: $907.37 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 1.11

Current Insider Ownership Percentage: 36.10%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 3
Amount Of Insider Selling (Last 12 Months): $13.87 M

Insider Buying and Selling by Quarter

Get KROS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Keros Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Keros Therapeutics (NASDAQ:KROS) Insider Trading History

Export to Excel

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/11/2022	Jennifer Lachey	Insider	Sell	5,300	$41.90	$222,070.00	85,700
4/11/2022	Jennifer Lachey	Insider	Sell	5,300	$62.77	$332,681.00	85,700
4/6/2022	Christopher Rovaldi	COO	Sell	1,728	$65.00	$112,320.00
4/4/2022	Jennifer Lachey	Insider	Sell	7,950	$60.00	$477,000.00	85,700
3/11/2022	Jennifer Lachey	Insider	Sell	2,650	$53.38	$141,457.00
2/11/2022	Jennifer Lachey	Insider	Sell	2,650	$52.06	$137,959.00
1/11/2022	Jennifer Lachey	Insider	Sell	2,650	$53.75	$142,437.50
1/5/2022	Jennifer Lachey	Insider	Sell	2,650	$60.00	$159,000.00
1/5/2022	Julius Knowles	Director	Sell	4,034	$58.25	$234,980.50
1/3/2022	Julius Knowles	Director	Sell	23,555	$58.01	$1,366,425.55

12/15/2021	Jennifer Lachey	Insider	Sell	735	$50.00	$36,750.00
12/13/2021	Jennifer Lachey	Insider	Sell	1,915	$50.55	$96,803.25
11/10/2021	Jennifer Lachey	Insider	Sell	15,900	$60.00	$954,000.00
11/3/2021	Julius Knowles	Director	Sell	15,967	$41.95	$669,815.65
11/1/2021	Julius Knowles	Director	Sell	23,803	$42.15	$1,003,296.45
10/20/2021	Julius Knowles	Director	Sell	4,082	$38.24	$156,095.68
10/18/2021	Julius Knowles	Director	Sell	13,786	$37.70	$519,732.20
10/14/2021	Julius Knowles	Director	Sell	4,383	$40.13	$175,889.79
10/4/2021	Julius Knowles	Director	Sell	3,746	$40.06	$150,064.76
10/1/2021	Julius Knowles	Director	Sell	6,323	$40.16	$253,931.68
9/27/2021	Julius Knowles	Director	Sell	95,302	$41.17	$3,923,583.34
7/1/2021	Julius Knowles	Director	Sell	23,834	$41.28	$983,867.52
6/11/2021	Jennifer Lachey	Insider	Sell	2,650	$50.98	$135,097.00	1,000
6/7/2021	Julius Knowles	Director	Sell	12,796	$49.89	$638,392.44
6/3/2021	Julius Knowles	Director	Sell	7,895	$47.97	$378,723.15
6/1/2021	Julius Knowles	Director	Sell	8,812	$52.51	$462,718.12
5/3/2021	Julius Knowles	Director	Sell	44,816	$57.48	$2,576,023.68
4/12/2021	Claudia Ordonez	Insider	Sell	1,000	$59.93	$59,930.00	1,000
4/5/2021	Julius Knowles	Director	Sell	27,151	$60.07	$1,630,960.57
4/1/2021	Julius Knowles	Director	Sell	11,202	$58.89	$659,685.78
3/3/2021	Julius Knowles	Director	Sell	12,327	$57.36	$707,076.72
3/1/2021	Julius Knowles	Director	Sell	12,979	$63.09	$818,845.11
2/18/2021	Julius Knowles	Director	Sell	28,617	$60.87	$1,741,916.79
2/11/2021	Claudia Ordonez	Insider	Sell	1,000	$64.84	$64,840.00	1,000
2/11/2021	Julius Knowles	Director	Sell	11,561	$64.82	$749,384.02
11/17/2020	Ran Nussbaum	Director	Buy	60,000	$50.00	$3,000,000.00

(Data available from 1/1/2013 forward)

Keros Therapeutics (NASDAQ:KROS) Insider Trade Frequently Asked Questions

Who is on Keros Therapeutics's Insider Roster?: The list of insiders at Keros Therapeutics includes Christopher Rovaldi, Claudia Ordonez, Jennifer Lachey, Julius Knowles, and Ran Nussbaum. Learn more on insiders at KROS.
What percentage of Keros Therapeutics stock is owned by insiders?: 36.10% of Keros Therapeutics stock is owned by insiders. Learn more on KROS's insider holdings.
Which Keros Therapeutics insiders have been buying company stock?: The following insider purchased Keros Therapeutics stock in the last 24 months: Ran Nussbaum ($3,000,000.00).

How much insider buying is happening at Keros Therapeutics?: Insiders have purchased a total of 60,000 Keros Therapeutics shares in the last 24 months for a total of $3,000,000.00 bought.
Which Keros Therapeutics insiders have been selling company stock?: The following insiders have sold Keros Therapeutics stock in the last 24 months: Christopher Rovaldi ($112,320.00), Claudia Ordonez ($124,770.00), Jennifer Lachey ($2,835,254.75), and Julius Knowles ($19,801,409.50).
How much insider selling is happening at Keros Therapeutics?: Insiders have sold a total of 451,049 Keros Therapeutics shares in the last 24 months for a total of $22,873,754.25 sold.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources